| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |